{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:12:53Z","timestamp":1770491573506,"version":"3.49.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sexual Medicine Reviews"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.sxmr.2020.01.005","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T15:50:00Z","timestamp":1584546600000},"page":"340-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Review of Intralesional Collagenase Clostridium Histolyticum Injection Therapy and Related Combination Therapies in the Treatment of Peyronie's Disease (an Update)"],"prefix":"10.1093","volume":"9","author":[{"given":"Caleb","family":"Natale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayad","family":"Yousif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne J.G.","family":"Hellstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.sxmr.2020.01.005_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11930-015-0045-y","article-title":"Peyronie's disease: a review of etiology, diagnosis, and management","volume":"7","author":"Bilgutay","year":"2015","journal-title":"Curr Sex Health Rep"},{"key":"10.1016\/j.sxmr.2020.01.005_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","article-title":"The prevalence of Peyronie's disease: results of a large survey","volume":"88","author":"Schwarzer","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2020.01.005_bib3","first-page":"745","article-title":"American Urological association Education and Research, Inc.,. Peyronie's disease: AUA Guideline","volume":"194","author":"Nehra","year":"2015","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.01.005_bib4","first-page":"199","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.01.005_bib5","first-page":"777","article-title":"Intralesional collagenase Clostridium histolyticum Causes Meaningful improvement in men with Peyronie's disease: results of a multi-institutional analysis","volume":"201","author":"Hellstrom","year":"2019","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.01.005_bib6","first-page":"905","article-title":"Evidence-based management Guidelines on Peyronie's disease","volume":"13","author":"Chung","year":"2016","journal-title":"J\u00a0Sex Med"},{"issue":"Suppl. 4","key":"10.1016\/j.sxmr.2020.01.005_bib7","first-page":"S21","article-title":"Can an external penis stretcher reduce Peyronie\u2019s penile curvature?","volume":"13","author":"Scroppo","year":"2001","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2020.01.005_bib8","first-page":"288","article-title":"Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease","volume":"9","author":"Abern","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.01.005_bib9","first-page":"754","article-title":"The effect of duration of penile traction therapy in patients undergoing intralesional injection therapy for Peyronie's disease","volume":"194","author":"Yafi","year":"2015","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.01.005_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.urology.2018.07.039","article-title":"The effect of Adjunct Mechanical traction on penile length in men undergoing primary treatment for Peyronie's disease: a systematic review and meta-analysis","volume":"122","author":"Haney","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2020.01.005_bib11","first-page":"2268","article-title":"Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease","volume":"187","author":"Gelbard","year":"2012","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.01.005_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.urology.2017.01.054","article-title":"Clinical experience with penile traction therapy among men undergoing collagenase Clostridium histolyticum for peyronie disease","volume":"104","author":"Ziegelmann","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2020.01.005_bib13","first-page":"599","article-title":"Outcomes of a novel penile traction device in men with Peyronie's disease: a randomized, single-blind, controlled trial","volume":"202","author":"Ziegelmann","year":"2019","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.01.005_bib14","first-page":"891","article-title":"Efficacy of combined collagenase Clostridium histolyticum and RestoreX penile traction therapy in men with Peyronie's disease","volume":"16","author":"Alom","year":"2019","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.01.005_bib15","first-page":"1472","article-title":"Sildenafil 25 mg ODT\u00a0+ collagenase Clostridium hystoliticum vs collagenase Clostridium hystoliticum alone for the management of Peyronie's disease: a matched-pair Comparison analysis","volume":"15","author":"Cocci","year":"2018","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.01.005_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.niox.2003.12.002","article-title":"L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures","volume":"9","author":"Valente","year":"2003","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.sxmr.2020.01.005_bib17","doi-asserted-by":"crossref","first-page":"e2298","DOI":"10.1016\/S1569-9056(19)31678-1","article-title":"How to improve your Xiapex results in Peyronie\u2019s disease: the Percutaneous Needle Tunnelling (PNT) technique. Step-by-step surgical video","volume":"18","author":"Fernandez Pascual","year":"2019","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.sxmr.2020.01.005_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jhsa.2017.03.003","article-title":"Injectable collagenase versus percutaneous needle fasciotomy for Dupuytren contracture in Proximal Interphalangeal Joints: a randomized controlled trial","volume":"42","author":"Skov","year":"2017","journal-title":"J\u00a0Hand Surg Am"},{"key":"10.1016\/j.sxmr.2020.01.005_bib19","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/bju.14784","article-title":"Optimizing collagenase Clostridium histolyticum therapy for Peyronie's disease using a novel approach with percutaneous needle tunnelling","volume":"124","author":"Fern\u00e1ndez-Pascual","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2020.01.005_bib20","first-page":"e160","article-title":"Clinical outcomes of the use of Collagenase Clostridium Histolyticum (CCH) for Peyronie\u2019s disease (PD)","volume":"14","author":"Pascual","year":"2017","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.01.005_bib21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.sxmr.2018.09.007","article-title":"Review of management options for active-phase Peyronie's disease","volume":"7","author":"Brimley","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.sxmr.2020.01.005_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.urology.2016.04.049","article-title":"Peyronie's disease and injectable collagenase Clostridium histolyticum: safety, efficacy, and improvements in subjective Symptoms","volume":"94","author":"Yang","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2020.01.005_bib23","first-page":"1220","article-title":"Safety and efficacy of collagenase Clostridium histolyticum in the treatment of acute-phase Peyronie's disease","volume":"14","author":"Nguyen","year":"2017","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.01.005_bib24","first-page":"1704","article-title":"Intralesional injection of interferon-\u03b12b Improves penile curvature in men with Peyronie's disease independent of plaque location","volume":"194","author":"Stewart","year":"2015","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.01.005_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.urology.2019.01.055","article-title":"Safety and efficacy of collagenase Clostridium histolyticum in Peyronie's disease men with ventral curvatures","volume":"129","author":"Alom","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2020.01.005_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5534\/wjmh.190026","article-title":"How atypical penile curvature Influence clinical outcomes in patients with Peyronie's disease receiving collagenase Clostridium histolyticum therapy?","volume":"38","author":"Cocci","year":"2020","journal-title":"World J Mens Health"},{"key":"10.1016\/j.sxmr.2020.01.005_bib27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bju.13932","article-title":"Safety and effectiveness of collagenase Clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol","volume":"120","author":"Abdel Raheem","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2020.01.005_bib28","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.sxmr.2019.05.001","article-title":"Discontinuation from collagenase Clostridium histolyticum therapy for Peyronie's disease: review and single-center cohort analysis","volume":"7","author":"Amighi","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.sxmr.2020.01.005_bib29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00345-019-02812-9","article-title":"A\u00a0modified technique for intralesional injection of collagenase Clostridium histolyticum for Peyronie's disease results in reduced procedural morbidity using a standardized hematoma classification rubric","volume":"38","author":"Amighi","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.sxmr.2020.01.005_bib30","first-page":"684","article-title":"Results of SMSNA survey Regarding complications following intralesional injection therapy with collagenase Clostridium histolyticum for Peyronie's disease","volume":"13","author":"Yafi","year":"2016","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.01.005_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4111\/icu.2017.58.4.255","article-title":"Efficacy of magnetic resonance imaging for diagnosis of penile fracture: a controlled study","volume":"58","author":"Saglam","year":"2017","journal-title":"Investig Clin Urol"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052120300093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052120300093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T19:37:59Z","timestamp":1672774679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2050052120300093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2050052120300093"],"URL":"https:\/\/doi.org\/10.1016\/j.sxmr.2020.01.005","relation":{},"ISSN":["2050-0521"],"issn-type":[{"value":"2050-0521","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of Intralesional Collagenase Clostridium Histolyticum Injection Therapy and Related Combination Therapies in the Treatment of Peyronie's Disease (an Update)","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sxmr.2020.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}